Expression profile of agonistic Smads in human breast cancer cells: Absence of regulation by estrogens

International Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 98-103

  Pouliot, Frederic ^b   Labrie, Claude ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; ESTROGEN; MEMBRANE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOKINE RELEASE; GENE DELETION; HOMOZYGOTE; HORMONAL REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; DIHYDROTESTOSTERONE; DNA-BINDING PROTEINS; ESTROGENS; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; RNA, MESSENGER; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0002494423     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990331)81:1<98::AID-IJC17>3.0.CO;2-9     Document Type: Article

References (21)

1. ARRICK, B.A., KORC, M. and DERYNCK, R., Differential regulation of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res., 50, 299-303 (1990).
2. ARTEAGA, C.L., TANDON, A.K., VON HOFF, D.D. and OSBORNE, C.K., Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res., 48, 3898-3904 (1988).
3. CANDIA, A.F., WATABE, T., HAWLEY, S.H., ONICHTCHOUK, D., ZHANG, Y., DERYNCK, R., NIEHRS, C. and CHO, K.W., Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development, 124, 4467-4480 (1997).
4. CHEN, X., WEISBERG, E., FRIDMACHER, V., WATANABE, M., NAC, G. and WHITMAN, M., Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature, 389, 85-89 (1997).
5. DE WINTER, J.P., ROELEN, B.A.J., TEN DIJKE, P., VAN DER BURG, B. and VAN DEN EIJDEN-VAN RAAIJ, A.J.M., DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene, 14, 1891-1899 (1997).
6. EPPERT, K. and 12 OTHERS, MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86, 543-552 (1996).
7. FENG, X.-H., ZHANG, Y., WU, R.-Y. and DERYNCK, R., The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Develop., 12, 2153-2163 (1998).
8. FISZER-SZAFARZ, B., SZAFARZ, D. and GUENEVARA-DE-MURILLO, A., A general, fast, and sensitve micromethod for DNA determination: application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells. Anal. Biochem., 110, 165-170 (1981).
9. HU, P.P.-C., DATTO, M.B. and WANG, X.F., Molecular mechanisms of transforming growth factor-β signaling. Endocrinol. Rev., 19, 349-363 (1998)
10. IAYARONE, A. and MASSAGUÉ, J., Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature (Lond.), 387, 417-422 (1997).
11. JENG, M.-H., TEN DIJKE, P., IWATA, K.K. and JORDAN, V.C., Regulation of the levels of three transforming growth factor β mRNAs by estrogen and their effects on the proliferation of human breast cancer cells. Mol. cell. Endocrinol., 97, 115-123 (1993).
12. KALKHOVEN, E., ROELEN, B.A.J., DE WINTER, J.P., MUMMERY, C.L., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., VAN DER SAAG, P.T. and VAN DER BURG, B., Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differentiation, 6, 1151-1161 (1995).
13. KNABBE, C., LIPPMAN, M.E., WAKEFIELD, L.M., FLANDERS, K.C., KASID, A., DERYNCK, R. and DICKSON, R.B., Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48, 417-428 (1987).
14. LANDIS, S.H., BOLDEN, S. and WINGO, P.A., Cancer statistics 1998. CA Cancer J. Clin., 48, 6-30 (1998).
15. NAKAO, A., AFRAKHTE, M., MORN, A., NAKAYAMA, T., CHRISTIAN, J.L., HEUCHEL, R., ITOH, S., KAWABATA, M., HELDIN, N.-E., HELDIN, C.-H. and TEN DIJKE, P., Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. Nature (Lond.), 389, 631-635 (1997).
16. POULIN, R., BAKER, D. and LABRIE, F., Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat., 12, 213-225 (1988).
17. SCHUTTE, M. and 14 OTHERS, DPC4 gene in various tumor types. Cancer Res., 56, 2527-2530 (1996).
18. SUN, L.Z., WU, G., WILLSON, J.K.V., ZBOROWSKA, E., YANG, J., RAJKARUNANAYAKE, I., WANG, J., GENTRY, L.E., WANG, X.-F. and BRATTAIN, M.G., Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. biol. Chem., 269, 26449-26455 (1994).
19. TAKENOSHITA, S., MOGI, A., NAGASHIMA, M., YANG, K., YAGI, K., HANYU, A., NAGAMACHI, Y., MIYAZONO, K. and HAGIWARA, K., Characterization of the MADH2/Smad2 gene, a human mad homolog responsible for the transforming growth factor-β and activin signal transduction pathway. Genomics, 48, 1-11 (1998).
20. YAMAMOTO, N., AKIMAYA, S., KATAGIRI, T., NAMIKI, M., KUROKAWA, T. and SUDA, T., Smad1 and Smad5 act downstream of intracellular signaling of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem. biophys. Res. Comm., 238, 574-580 (1997).
21. ZHANG, Y., FENG, X.-H., WU, R.-Y. and DERYNCK, R., Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature (Lond.), 383, 168-172 (1996).